2 Vol 2, ESRD, Ch 2 Data Source: Special analyses, Medicare 5 percent sample. Medicare - PowerPoint Presentation

1.

2. 2Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Medicare patients age 65 & older with a hospitalized AKI event in given year. Abbreviations: Af Am, African American; AKI, acute kidney injury; CKD, chronic kidney disease.vol 2 Table 2.1 HP2020 CKD-3 Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post-discharge: Target 12.3%2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All2.43.14.58.49.110.511.210.611.511.912.813.2American Indian or Alaskan Native only0.00.02.916.74.813.212.015.26.911.016.711.5Asian only3.82.04.58.112.619.015.211.416.715.416.516.8Black or Af Am only2.92.54.07.99.89.211.310.412.311.312.313.5White only2.33.24.58.38.810.511.110.411.211.912.713.0Hispanic or Latino1.46.67.112.812.210.112.415.513.513.617.115.0Male2.83.54.68.89.911.312.611.912.512.814.014.3Female2.02.84.38.08.39.710.09.410.611.111.812.265-743.64.26.211.712.914.716.114.816.016.517.717.675-842.03.24.28.58.610.411.110.811.312.413.313.485+0.81.12.23.14.45.15.15.06.45.96.27.4

3. 3vol 2 Table 2.2 HP2020 D-12 Increase the proportion of persons with diagnosed diabetes who obtain an annual urine albumin measurement: Target 36.6%Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Medicare patients with diabetes mellitus, age 65 & older. Abbreviations: Af Am, African American; D, diabetes mellitus.2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All15.318.121.225.528.531.033.335.336.938.640.542.4American Indian or Alaskan Native only11.412.013.015.518.920.220.921.124.122.924.623.9Asian only16.820.623.928.830.433.434.937.339.541.743.847.4Black or Af Am only13.115.618.523.526.429.031.533.335.336.939.040.6White only15.518.521.625.728.731.233.535.537.138.740.642.4Hispanic or Latino15.417.820.725.529.631.333.235.137.540.242.344.3Male15.918.821.926.529.431.934.536.437.939.541.643.3Female14.817.620.724.727.830.232.434.436.237.739.641.665-7418.121.224.729.432.635.137.739.941.843.345.347.375-8413.716.719.623.826.829.631.833.735.337.139.141.085+7.29.010.913.916.118.120.522.223.525.026.728.0

4. 4vol 2 Table 2.3 HP2020 CKD-4.1 Increase the proportion of persons with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and urine albumin: Target 28.3%Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Medicare patients age 65 & older with CKD. Abbreviations: Af Am, African American; CKD, chronic kidney disease.2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All7.39.110.619.822.123.425.726.728.129.030.231.2American Indian or Alaskan Native only8.25.57.013.719.215.816.916.718.420.321.118.6Asian only8.414.414.127.527.932.535.334.137.636.939.541.2Black or Af Am only6.68.710.120.822.824.426.727.830.130.632.333.2White only7.18.810.419.321.622.925.126.327.428.329.430.4Hispanic or Latino13.117.317.726.830.531.133.032.036.036.738.941.3Male7.59.311.321.123.424.527.128.429.630.632.033.1Female7.08.910.018.620.922.324.325.226.727.628.629.565-7410.312.614.226.129.231.433.935.136.737.738.940.075-846.28.09.818.520.822.624.926.227.728.930.331.285+2.33.14.08.210.010.112.113.114.014.816.217.0

5. Vol 2, ESRD, Ch 25Data Source: Special analyses, Medicare 5 percent sample. Medicare patients age 65 & older with CKD & diabetes mellitus. Abbreviations: Af Am, African American; CKD, chronic kidney disease; HgbA1c, glycosylated hemoglobin.vol 2 Table 2.4 HP2020 CKD-4.2 Increase the proportion of persons with Type 1 or Type 2 diabetes and chronic kidney disease who receive medical evaluation with serum creatinine, urine albumin, HgbA1c, lipids, and eye examinations: Target 25.3%2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All9.010.412.118.420.021.123.023.725.126.526.927.7American Indian or Alaskan Native only7.32.45.75.615.812.510.210.910.915.114.211.5Asian only8.312.412.824.921.826.126.725.327.029.630.832.5Black or Af Am only6.77.29.916.317.918.819.721.122.423.825.125.4White only9.411.012.518.620.321.423.424.225.627.027.128.0Hispanic or Latino10.411.811.820.420.319.822.221.724.624.026.525.3Male9.310.612.418.820.321.423.523.725.626.727.327.9Female8.710.311.818.019.720.922.523.624.726.226.627.565-7410.912.314.322.023.424.626.627.228.530.030.130.875-848.19.911.616.918.920.722.623.325.226.727.428.485+4.04.24.99.511.511.313.014.215.516.617.718.4

6. 6Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Adj: overall, age/sex/race; rates by age adjusted for sex/race; rates by sex adjusted for age/race; rates by race/ethnicity adjusted for age/sex. Reference: 2011 patients. “.” Zero values in this cell. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: Adj, adjusted; Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2vol 2 Table 2.5 HP2020 CKD-8 Reduce the rate of new cases of end-stage renal disease: Target 347.7 new cases per million population 200120022003200420052006200720082009201020112012All384.0384.6384.6384.1387.5394.4386.3382.3385.7378.7362.3359.2American Indian or Alaskan Native only704.3671.6618.2636.0613.0523.2536.0548.8539.8498.4473.3469.9Asian only319.9312.9304.6282.0337.8355.2357.1357.3365.3358.5350.3343.8Native Hawaiian or other Pacific Islander only~3368.23505.63464.83650.92872.82781.52370.62125.02376.32565.52321.62527.7Black or Af Am only1120.11126.61126.11088.91099.71109.31085.51069.71070.81034.0995.1955.4White only291.4292.3292.5296.8301.0309.5303.6301.4305.9303.3289.9290.7Two or more races.....122.6113.1112.089.271.247.316.1Hispanic or Latino622.4632.1631.0607.2594.0594.9580.6576.4573.7568.9554.5521.1Not Hispanic or Latino368.0368.3369.1370.4373.3378.6371.6368.3372.5365.7350.0349.1Black or Af Am only, not Hispanic or Latino1136.51144.01143.81103.51116.01126.01105.11088.91088.41053.31012.9975.4White only, not Hispanic or Latino267.3266.3266.3271.8274.1279.1273.3270.1273.5269.6255.9259.1

7. 7Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Adj: overall, age/sex/race; rates by age adjusted for sex/race; rates by sex adjusted for age/race; rates by race/ethnicity adjusted for age/sex. Reference: 2011 patients. “.” Zero values in this cell. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: Adj, adjusted; Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2vol 2 Table 2.5 HP2020 CKD-8 Reduce the rate of new cases of end-stage renal disease: Target 347.7 new cases per million population (continued)200120022003200420052006200720082009201020112012Male459.8465.8465.2473.0479.6489.2481.5479.0484.4477.0456.9452.4Female323.6320.3321.0313.3314.5318.6310.8305.5307.2300.0285.9283.7<1812.012.312.412.712.611.512.312.112.011.611.811.70-49.68.39.711.110.29.111.110.210.911.311.511.65-117.89.37.98.08.06.57.07.67.27.26.97.512-1718.919.120.019.520.019.219.518.918.417.017.816.718-44113.5112.7111.7112.9117.5121.2119.4118.7122.4118.9115.6115.218-2444.542.342.639.642.243.342.541.340.439.439.636.325-44137.6137.3135.9138.5143.9148.5146.3145.8151.1146.7142.1142.945-64617.6607.3608.8602.3603.5613.7598.4594.0594.4577.8558.0562.245-54391.4389.4391.9390.3388.0404.1391.1386.9389.6375.2372.8373.355-64843.9825.2825.7814.3819.1823.3805.6801.0799.1780.3743.1751.165+1585.21629.41619.01616.41634.91657.71624.51602.11614.71609.21526.41476.765-741441.51429.31410.21400.91389.71416.21381.11354.91364.11359.61275.71252.375-841761.01857.91848.31850.11896.81917.01878.91856.71871.31871.01792.61716.085+1264.61346.61414.51433.51469.31479.21514.31527.61555.01486.71372.61327.1

8. 8Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Incident ESRD patients. Adj: age/sex/race; Reference: 2011. “.” Zero values in this cell. *Values for cells with 10 or fewer patients are suppressed. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: Adj, adjusted; Af Am, African American; CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2vol 2 Table 2.6 HP2020 CKD-9.1 Reduce kidney failure due to diabetes: Target 151.9 per million population 200120022003200420052006200720082009201020112012All175.1172.3171.4171.3171.6174.6168.7166.2167.0164.4157.0154.0American Indian or Alaskan Native only519.8492.2464.8475.0427.5363.0376.9391.2388.0353.2327.5318.3Asian only150.8142.0138.3128.2159.5176.4171.4178.9179.7172.8173.5165.1Native Hawaiian or other Pacific Islander only~2158.01960.91966.12220.11664.71700.41467.61283.71476.31609.11411.81462.8Black or Af Am only519.7513.8504.0490.7492.1495.6473.5468.7466.7452.4431.2402.4White only132.0130.6130.8132.7133.9137.8134.3132.2133.5132.9127.5127.2Two or more races.....59.458.749.042.329.318.44.6Hispanic or Latino397.4398.8400.6386.1371.7368.9360.5361.2353.5351.0340.1315.5Not Hispanic or Latino162.3159.4158.7159.6159.7162.0156.5154.2155.6153.1146.1144.7Black or Af Am only, not Hispanic/Latino527.5521.3511.3497.1499.3503.3481.4476.7475.2460.4438.7411.6White only, not Hispanic or Latino113.5111.1110.7113.0113.2115.1111.4108.1109.2108.0102.2103.6

9. 9Vol 2, ESRD, Ch 2Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Incident ESRD patients. Adj: age/sex/race; Reference: 2011. “.” Zero values in this cell. *Values for cells with 10 or fewer patients are suppressed. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: Adj, adjusted; Af Am, African American; CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease; ESRD, end-stage renal disease.vol 2 Table 2.6 HP2020 CKD-9.1 Reduce kidney failure due to diabetes: Target 151.9 per million population (continued)200120022003200420052006200720082009201020112012Male191.5192.2191.9197.5199.3203.5199.1197.8200.2198.0190.1186.5Female161.2155.5154.3149.5148.4150.2143.4140.0139.3136.2129.2126.4<180.10.10.10.10.10.1*0.10.10.10.10.10-4*****0.2.*0.30.3*0.25-11.0.1..*..*...*12-17****0.2*******18-4433.832.833.634.435.238.537.837.539.939.639.737.818-243.72.93.02.13.13.22.72.42.62.52.32.425-4444.343.344.345.746.550.950.249.853.052.652.850.145-64344.2333.8329.3324.1323.5323.3309.9307.9306.6295.0280.6281.145-54191.7188.8187.3185.6182.9189.2179.2178.1179.8175.6173.0173.955-64496.8478.8471.4462.5464.2457.5440.6437.6433.3414.5388.3388.365+679.1688.9682.4690.1694.8705.8690.0672.8673.1678.9645.4611.165-74749.6734.6727.7721.3712.1724.4697.2676.9674.6668.1630.1607.575-84649.1682.2673.4693.2714.1722.0715.1698.4700.0719.2689.4641.185+274.9298.4318.4345.9329.3358.0366.4376.7389.8383.8358.5345.6

10. 10Vol 2, ESRD, Ch 2vol 2 Table 2.7 HP2020 CKD-9.2 Reduce kidney failure due to diabetes among persons with diabetes: Target 2,356 per million population Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Incident ESRD patients. Adj: age/sex/race; Ref: 2011. NHIS 2006–2012 used to estimate diabetes mellitus prevalence; “.” Zero values in this cell. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Adj, adjusted; Af Am, African American; CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease; ESRD, end-stage renal disease; NHIS, National Health Interview Survey; Ref, reference.200720082009201020112012All2,6182,4872,4052,3502,2762,245American Indian or Alaskan Native only2,5852,9682,9922,6672,3062,278Asian only2,0912,2132,2472,1542,1242,137Native Hawaiian or other Pacific Islander only......Black or Af Am only4,4924,3474,2623,9963,8413,670White only2,2782,1412,0542,0331,9761,967Two or more races44734627319615836Hispanic or Latino3,3133,1702,9552,9032,8952,772Not Hispanic or Latino2,5172,3892,3222,2642,1812,159Black or Af Am only, not Hispanic/Latino4,6984,5364,4894,2044,0753,871White only, not Hispanic or Latino2,0501,9031,8291,8061,7341,751

11. 11Vol 2, ESRD, Ch 2vol 2 Table 2.7 HP2020 CKD-9.2 Reduce kidney failure due to diabetes among persons with diabetes: Target 2,356 per million population (continued)Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset Incident ESRD patients. Incident ESRD patients. Adj: age/sex/race; Ref: 2011. NHIS 2006–2012 used to estimate diabetes mellitus prevalence; “.” Zero values in this cell. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Adj, adjusted; Af Am, African American; CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease; ESRD, end-stage renal disease; NHIS, National Health Interview Survey; Ref, reference.200720082009201020112012Male2,9312,7452,6272,5472,5232,516Female2,3272,2362,1802,1442,0261,975<18*34345135590-4......5-11*....*12-17******18-441,6131,5321,5071,4621,5611,49718-2434127228929333829125-441,7481,6781,6421,5791,6681,63245-642,3802,2572,1992,1392,0722,09645-542,0101,8441,8551,8691,8791,87455-642,6452,5732,4412,3132,1822,23365+3,1022,9412,8072,7282,5792,48965-743,1882,9932,9002,7762,6242,54475-843,3513,1592,9412,8842,8042,70285+1,9502,0691,9852,0851,7741,688

12. 12Data Source: Special analyses, Medicare 5 percent sample. Incident hemodialysis patients with a valid ESRD Medical Evidence CMS 2728 form; nephrologist care determined from Medical Evidence form. Abbreviations: Af Am, African American; CMS, Centers for Medicare and Medicaid Services; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2Vol 2 Table 2.8 HP2020 CKD-10 Increase the proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy: Target 30.0% 2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All25.726.427.328.628.629.631.033.1American Indian or Alaskan Native only25.427.026.027.927.224.228.330.1Asian only25.824.026.727.729.329.931.632.1Native Hawaiian or other Pacific Islander only23.225.424.022.023.825.327.127.4Black or Af Am only22.223.124.124.725.025.527.229.7White only27.328.028.830.430.231.332.734.7Two or more races21.421.622.127.526.025.925.025.0Hispanic or Latino20.021.321.422.322.623.725.125.9Not Hispanic or Latino26.627.228.229.629.530.532.134.4Black or Af Am only, not Hispanic/Latino22.223.224.124.725.025.627.329.8White only, not Hispanic or Latino28.829.430.532.332.033.234.737.0

13. 13Vol 2, ESRD, Ch 2vol 2 Table 2.8 HP2020 CKD-10 Increase the proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy: Target 30.0% (continued)Data Source: Special analyses, Medicare 5 percent sample. Incident hemodialysis patients with a valid ESRD Medical Evidence CMS 2728 form; nephrologist care determined from Medical Evidence form. Abbreviations: Af Am, African American; CMS, Centers for Medicare and Medicaid Services; CKD, chronic kidney disease; ESRD, end-stage renal disease.2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)Male26.126.527.328.428.329.630.833.2Female25.326.327.328.828.929.531.433.1<1839.736.135.140.139.137.744.740.70-425.019.826.026.922.823.325.226.65-1150.548.940.753.147.749.058.351.712-1741.437.036.740.442.239.347.742.518-4423.323.023.724.423.924.325.827.818-2424.723.225.024.024.825.427.626.525-4423.222.923.524.523.824.225.627.945-6425.726.126.727.327.427.929.531.245-5424.125.025.525.325.826.228.429.555-6426.826.927.428.628.529.030.132.265+26.127.528.630.530.532.033.435.965-7427.028.428.930.630.732.033.435.675-8425.927.328.931.230.932.733.936.785+22.924.226.627.628.429.731.634.2

14. 14Vol 2, ESRD, Ch 2vol 2 Table 2.9 HP2020 CKD-11.3 Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas or have a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy: Target 35.0%Data Source: Special analyses, Medicare 5 percent sample. Incident hemodialysis patients age 18 & older. Abbreviations: Af Am, African American; CKD, chronic kidney disease.2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All31.232.131.831.332.433.935.236.8American Indian or Alaskan Native only36.539.138.041.641.340.940.640.7Asian only36.337.735.535.935.837.637.338.1Native Hawaiian or other Pacific Islander only40.634.935.632.732.332.836.037.7Black or Af Am only28.529.429.929.330.832.234.136.0White only32.032.932.331.932.834.435.537.1Two or more races23.036.229.324.833.231.333.038.1Hispanic or Latino31.532.430.029.831.132.833.634.5Not Hispanic or Latino31.132.032.031.632.634.135.537.3Black or Af Am only, not Hispanic/Latino28.429.329.929.230.732.034.036.0White only, not Hispanic or Latino32.133.032.932.433.334.936.237.9

15. 15Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Incident hemodialysis patients age 18 & older. Abbreviations: Af Am, African American; CKD, chronic kidney disease.2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)Male35.135.335.034.035.036.438.039.3Female26.428.027.627.829.030.631.533.518-4429.629.728.327.629.331.132.032.718-2425.922.720.921.023.023.724.926.125-4430.030.429.128.329.931.832.733.445-6433.333.532.732.633.434.436.038.045-5432.533.232.532.233.034.136.037.355-6433.933.732.932.933.634.736.038.465+30.031.631.831.132.434.135.336.865-7431.833.634.233.034.436.037.139.075-8429.430.830.730.932.033.935.136.385+23.725.225.424.325.526.728.429.2vol 2 Table 2.9 HP2020 CKD-11.3 Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas or have a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy: Target 35.0% (continued)

16. 16Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. * Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2vol 2 Table 2.10 HP2020 CKD-12 Increase the proportion of dialysis patients wait-listed and/or receiving a deceased donor kidney transplant within 1 year of end-stage renal disease start (among patients under 70 years of age): Target 18.7% of dialysis patients 2000(%)2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)All15.414.614.614.715.415.917.017.116.817.317.017.7American Indian or Alaskan Native only12.89.710.19.610.211.310.411.310.711.511.511.3Asian only27.029.128.028.332.128.231.330.831.332.332.133.1Native Hawaiian or other Pacific Islander only17.417.518.819.518.116.015.214.914.115.215.214.8Black or Af Am only11.210.510.710.611.612.113.113.313.313.913.914.5White only17.116.316.116.416.817.618.518.618.218.317.918.7Two or more races*****14.119.414.123.723.823.017.4Hispanic or Latino13.012.713.314.114.615.817.617.717.418.217.618.6Not Hispanic or Latino15.514.714.514.515.415.816.716.816.616.916.817.4Black or Af Am only, not Hispanic/Latino11.210.510.710.611.612.013.013.213.213.913.914.5White only, not Hispanic or Latino18.117.116.816.817.218.118.818.918.418.318.018.5

17. 17Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. * Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.vol 2 Table 2.10 HP2020 CKD-12 Increase the proportion of dialysis patients wait-listed and/or receiving a deceased donor kidney transplant within 1 year of end-stage renal disease start (among patients under 70 years of age): Target 18.7% of dialysis patients (continued)2000(%)2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)Male16.515.315.715.616.516.918.017.817.518.117.818.4Female13.413.412.713.113.714.315.315.815.715.815.816.5<1842.940.743.050.146.353.357.556.258.257.956.554.90-426.232.132.941.232.534.342.738.240.243.939.637.55-1144.849.545.650.351.965.065.366.769.865.964.962.512-1747.541.243.252.948.255.963.560.764.663.062.361.218-4429.527.627.726.127.826.928.927.827.627.927.128.918-2431.329.330.929.933.828.432.733.030.733.233.133.925-4426.224.923.923.424.624.825.825.225.025.424.726.745-6418.017.016.316.517.017.518.318.617.718.418.319.145-5418.517.417.116.716.817.018.318.617.318.418.018.855-6411.310.510.711.412.213.113.914.114.414.214.415.065+7.47.37.98.49.210.011.111.411.912.312.312.665-697.47.37.98.49.210.011.111.411.912.312.312.6

18. 18Vol 2, ESRD, Ch 2vol 2 Table 2.11 HP2020 CKD-13.1 Increase the proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease: Target 20.1%Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.1998(%)1999(%)2000(%)2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)All20.119.519.318.418.418.218.317.817.216.615.714.7American Indian or Alaskan Native only13.79.515.58.711.58.89.28.99.910.16.87.2Asian only19.218.718.719.121.021.820.318.519.017.618.116.8Native Hawaiian or other Pacific Islander only13.613.48.312.812.411.812.79.69.810.510.78.4Black or Af Am only9.89.59.88.89.69.210.09.69.09.08.77.7White only26.225.324.623.923.223.022.722.121.420.719.318.2Two or more races*******16.316.414.418.317.4Hispanic or Latino16.814.915.414.614.514.914.714.614.513.812.611.8Not Hispanic or Latino20.119.619.218.518.618.118.417.817.216.815.914.8Black or Af Am only, not Hispanic/Latino9.89.49.78.89.59.29.99.68.99.08.67.7White only, not Hispanic or Latino28.127.826.926.325.825.325.124.423.823.121.820.5

19. 19Vol 2, ESRD, Ch 219Vol 2, ESRD, Ch 2vol 2 Table 2.11 HP2020 CKD-13.1 Increase the proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease: Target 20.1% (continued)Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.1998(%)1999(%)2000(%)2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)Male21.620.520.119.319.619.219.218.718.117.216.015.0Female17.216.916.816.215.815.616.015.414.915.114.513.4<1875.175.973.272.972.777.576.276.978.778.977.178.20-478.781.878.177.076.679.277.274.676.676.768.574.75-1181.480.475.181.978.882.583.982.282.788.586.383.912-1770.772.171.067.068.574.872.775.778.176.376.777.518-4433.832.631.630.329.829.029.527.726.925.524.122.818-2444.442.744.042.639.942.542.640.037.935.934.335.025-4432.631.530.228.928.627.428.026.425.624.423.021.545-6416.315.716.115.315.115.115.215.014.614.113.312.445-5421.120.220.419.618.418.518.517.617.217.015.714.955-6412.612.112.611.912.512.512.713.212.712.111.710.765+5.36.06.36.57.47.78.17.98.38.38.37.965-695.36.06.36.57.47.78.17.98.38.38.37.9

20. 20Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.Vol 2, ESRD, Ch 2vol 2 Table 2.12 HP2020 CKD-13.2 Increase the proportion of patients who receive a preemptive transplant at the start of end-stage renal disease2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)All3.23.33.33.63.84.04.03.93.83.83.93.7American Indian or Alaskan Native only**1.5**1.4**1.7*1.61.1Asian only2.02.82.62.42.62.93.13.42.93.43.83.0Native Hawaiian or other Pacific Islander only******1.92.62.0***Black or Af Am only0.50.70.70.70.90.91.11.11.01.11.20.9White only3.94.14.04.54.85.05.24.94.64.64.74.2Two or more races****1.3*******Hispanic or Latino1.11.31.31.51.52.02.02.02.02.02.22.1Not Hispanic or Latino2.83.02.93.33.53.73.93.83.53.63.73.2Black or Af Am only, not Hispanic/Latino0.50.70.70.70.90.91.11.11.01.11.20.9White only, not Hispanic or Latino4.64.84.75.35.66.06.25.95.45.55.65.0

21. 21Vol 2, ESRD, Ch 2Data Source: Special analyses, Medicare 5 percent sample. Incident ESRD patients younger than 70. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease; ESRD, end-stage renal disease.vol 2 Table 2.12 HP2020 CKD-13.2 Increase the proportion of patients who receive a preemptive transplant at the start of end-stage renal disease (continued)2001(%)2002(%)2003(%)2004(%)2005(%)2006(%)2007(%)2008(%)2009(%)2010(%)2011(%)2012(%)Male2.72.82.83.03.23.63.73.43.33.33.42.9Female2.52.72.63.03.23.33.53.63.33.43.53.2<1819.518.721.119.323.525.222.022.326.323.926.225.20-417.612.718.817.417.617.619.411.919.216.119.417.65-1121.326.828.321.829.033.531.132.336.132.630.230.312-1719.216.418.719.023.424.719.522.325.023.527.726.618-445.75.85.46.05.76.36.06.05.85.66.05.618-248.58.68.98.98.810.38.49.19.39.59.29.625-445.45.55.05.75.45.85.85.75.55.25.65.245-642.52.62.83.13.33.53.63.43.23.43.33.145-543.53.63.73.94.24.34.64.23.94.34.03.855-641.81.92.12.42.62.83.02.92.72.82.92.765+0.70.91.21.31.61.91.82.01.92.12.32.265-690.70.91.21.31.61.91.82.01.92.12.32.2

22. 22Vol 2, ESRD, Ch 2vol 2 Table 2.13 HP2020 CKD-14.1 Reduce the total death rate for persons on dialysis: Target 193.2 deaths per 1,000 patient yearsData Source: Special analyses, Medicare 5 percent sample. Period prevalent dialysis patients. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012All240.7239.1237.4232.1228.5224214.7207.4201.6194.3190.2181.4American Indian or Alaskan Native only208.1199.2192.2183.6180170.8164.1167.9172150.8147.4143.5Asian only174.1164.3172.9168.2172.3160.4156.4142.2143.5134.6138132Native Hawaiian or other Pacific Islander only162.5180171.2165.3151.3161.7162.8149.1157.2153.1138.7132.2Black or Af Am only189.8186.7187.2186.2181.7176.2169.4163.1157.9150.2145.2138.8White only286.5286.2282.8274.1270.8266.2254.2245.8238.5231.9228217.3Two or more races****159166.5150.5157.1154.2140.7138125.3Hispanic or Latino178.3177.9175.9170.6167160.3149.7144.1145.7137.3136.5134.9Not Hispanic or Latino245.2246245.9241.7238.5234.9226.4219.1212.3205.4201191Black or Af Am only, not Hispanic/Latino190.2187187.6186.4182.1176.7170.1163.7158.3150.6145.5138.5White only, not Hispanic or Latino311.7312.3310.2302.6299.8297.6287.1280271.3266.4263251

23. 23Vol 2, ESRD, Ch 2vol 2 Table 2.13 HP2020 CKD-14.1 Reduce the total death rate for persons on dialysis: Target 193.2 deaths per 1,000 patient years (continued)Data Source: Special analyses, Medicare 5 percent sample. Period prevalent dialysis patients. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012Male235.2233233.4228.9225.3221.1212.3206201.6193.6189.4181.4Female246.8245.9242235.8232.3227.3217.7209.1201.7195.2191.2181.4<1848.948.164.949.44144.242.445.642.849.430.532.30-4132.184.293.77870.973.564.684.188.873.236.761.65-1137.731.363.353.83140.947.239.737.751**12-1733.346.459.641.637.438.235.636.931.442.129.623.418-44103.7104.7105.1101.199.796.893.586.284.679.977.774.218-2457.96156.158.856.253.551.951.145.944.746.444.525-44108.4109.2110.3105.5104.2101.397.889.988.683.680.977.245-64192.6189.4190.5186.1179.7177.8168.3163.5159.9154150.7144.645-54161159.3157.3154.4150.1149.7141.4137134.8128.3124.1118.955-64218.1213.8217.6212.1204200.6190184.8179.7174.1171.2164.165+362.2360.5354348347.5339.9329.4320.4310.9300.8295.4281.465-74308.1305.6298.8294.2291279.8268.1263.9256.4244.9241229.875-84426.6420.4411.9401.6402.9398.7387.5373.9358.5351.1344.4328.885+607.9614595.6578.4574.1562.2557.8521.8516.7500.9494.3468.6

24. 24Vol 2, ESRD, Ch 2vol 2 Table 2.14 HP2020 CKD-14.2 Reduce the death rate in dialysis patients within the first 3 months of initiation of renal replacement therapy: Target 329.0 deaths per 1,000 patient years at riskData Source: Special analyses, Medicare 5 percent sample. Incident dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012All381.0380.7386.9381.3377.8370.1365.6362.1352.2353.3335.8311.8American Indian or Alaskan Native only172.4146.8193.8209.2214.2158.0175.7237.3154.1151.6151.2218.2Asian only232.9226.0236.2231.9251.7207.8247.0203.3213.4216.5177.8187.1Native Hawaiian or other Pacific Islander only212.1181.3185.4187.7169.3219.3173.8149.2197.2163.3184.5122.4Black or Af Am only274.9266.4278.3274.9274.8267.2254.2253.6246.8243.0230.6206.7White only448.4454.3457.7447.4440.0432.6431.1428.1417.1419.8401.2372.8Two or more races****310.0302.4285.3302.1197.9262.8257.0*Hispanic or Latino247.9229.0243.5227.1241.1216.5219.0212.3206.8207.9204.2194.6Not Hispanic or Latino398.4401.9407.4403.2397.1392.9387.9385.7375.5377.7358.8331.5Black or Af Am only, not Hispanic/Latino275.9266.2279.0276.0274.7267.5255.9254.3247.3243.7232.1205.1White only, not Hispanic or Latino484.8498.8499.8491.8482.8483.5481.1482.5470.9476.5456.8421.7

25. 25Vol 2, ESRD, Ch 2vol 2 Table 2.14 HP2020 CKD-14.2 Reduce the death rate in dialysis patients within the first 3 months of initiation of renal replacement therapy: Target 329.0 deaths per 1,000 patient years at risk (continued)Data Source: Special analyses, Medicare 5 percent sample. Incident dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012Male383.1376.3386.1382.4372.5367.1367.4363.7357.0350.5335.8307.8Female378.7385.9387.8380.0384.2373.8363.2360.2346.1357.0335.7317.0<18***71.1********0-4************5-11************12-17************18-44101.6101.6103.7106.5105.7102.697.5100.3102.994.293.770.618-2474.060.062.574.759.991.766.956.950.266.372.7*25-44104.4105.9108.1109.7110.4103.7100.6104.8108.097.095.974.745-64215.0210.2217.5212.1213.6205.0199.3206.6202.9202.1193.6179.845-54158.9165.3168.6166.9174.8154.8156.0171.7160.6157.5149.2134.855-64256.9243.4252.9244.3240.5240.1228.6229.5230.3229.7221.4206.865+580.5580.5590.2583.0577.7571.5569.3555.5537.9539.2512.9480.565-74431.0427.9421.0422.2418.3401.4404.8405.2390.9391.6367.3349.875-84673.3674.3676.9668.9655.4656.0652.7615.7611.3610.8593.2545.985+1046.0982.91073.51009.6990.61007.9961.6964.4889.2912.1850.4837.2

26. 26Vol 2, ESRD, Ch 2vol 2 Table 2.15 HP2020 CKD-14.3 Reduce the cardiovascular death rate for persons on dialysis: Target 83.2 deaths per 1,000 patient years at riskData Source: Special analyses, Medicare 5 percent sample. Period prevalent dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012All122.1119.2116.3110.8104.598.392.487.784.781.678.375.5American Indian or Alaskan Native only105.795.390.383.977.27270.261.769.261.458.256.3Asian only97.391.196.28689.673.271.467.769.163.463.859.9Native Hawaiian or other Pacific Islander only102.4111.3102.789.37787.98073.68282.367.966.1Black or Af Am only92.791.389.387.683.479.474.571.368.464.561.260.4White only146.9142.9139.2131.2123114.7107.7101.697.895.492.188.1Two or more races****72.676.270.173.867.469.465.452.8Hispanic or Latino95.19387.984.480.374.36866.167.363.961.961.2Not Hispanic or Latino123.8121.9120.1114.8108.3102.496.791.6888581.678.5Black or Af Am only, not Hispanic/Latino92.991.389.587.583.479.674.771.568.564.761.360.2White only, not Hispanic or Latino159.2155.2152.5144.1134.8126.7120.2113.5108.4106.8103.599.1

27. 27Vol 2, ESRD, Ch 2vol 2 Table 2.15 HP2020 CKD-14.3 Reduce the cardiovascular death rate for persons on dialysis: Target 83.2 deaths per 1,000 patient years at risk (continued)Data Source: Special analyses, Medicare 5 percent sample. Period prevalent dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012Male121.7118.6116.8112.1105.299.893.689.88783.580.177.8Female122.6120115.7109.3103.696.590.98581.879.27672.6<1820.914.418.718.51718.414.115.217.717.21013.10-448.4*******38***5-11************12-1716.614.220.816.515.818.214.312.913.120.212.210.418-4447.848.648.645.945.14341.638.138.136.234.433.518-2422.226.526.125.325.922.721.819.821.420.319.919.225-4450.550.950.94847.145.143.64039.837.835.93545-6499.596.494.390.784.982.175.373.271.76966.464.445-5482.681.276.174.870.869.964.262.361.958.155.95455-64113.1108.8109.2103.896.591.984.381.979.477.474.572.465+184.4179.6173.9165.2156.1144.4137.8129.8123.9119.8115.1110.565-74158.9154.7147.9143.5132.7122.3116.5111.4106.4100.598.593.775-84214.8205.7200.3185.3179.6164.8157.8146.9137.1137.4128.2125.685+300.3303.6292.7267.5245.5234.1218.5197.8201.1188.4184.6174

28. 28Vol 2, ESRD, Ch 2vol 2 Table 2.16 HP2020 CKD-14.4 Reduce the total death rate for persons with a functioning kidney transplant: Target 27.1 deaths per 1,000 patient years at riskData Source: Special analyses, Medicare 5 percent sample. Period prevalent transplant patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012All33.331.732.430.631.530.830.128.829.829.529.927.2American Indian or Alaskan Native only37.734.831.836.037.546.033.531.850.345.042.130.2Asian only19.322.217.520.521.519.823.218.116.816.720.418.5Native Hawaiian or other Pacific Islander only30.832.324.523.537.719.017.218.426.718.917.019.8Black or Af Am only37.935.836.233.233.232.729.830.029.629.030.028.4White only33.031.432.730.831.631.231.129.430.730.630.727.7Two or more races****24.521.715.621.922.622.623.823.3Hispanic or Latino21.120.018.717.321.122.419.919.721.420.921.618.4Not Hispanic or Latino34.633.134.132.332.932.031.630.131.130.931.228.6Black or Af Am only, not Hispanic/Latino38.136.336.133.433.732.930.130.529.729.330.228.8White only, not Hispanic or Latino34.632.934.832.933.332.633.031.232.732.632.729.7

29. Vol 2, ESRD, Ch 229vol 2 Table 2.16 HP2020 CKD-14.4 Reduce the total death rate for persons with a functioning kidney transplant: Target 27.1 deaths per 1,000 patient years at risk (continued)Data Source: Special analyses, Medicare 5 percent sample. Period prevalent dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012Male35.433.533.732.933.932.731.930.431.131.631.928.8Female30.129.230.427.428.028.127.626.427.926.627.024.8<185.47.76.63.77.34.0**3.46.43.1*0-4************5-11************12-175.87.36.5*8.4****6.4**18-4414.813.812.211.911.411.210.59.49.78.77.96.818-248.53.85.17.27.27.85.76.36.46.14.24.725-4415.414.813.012.311.911.511.09.710.19.08.47.145-6438.434.935.731.832.931.029.127.426.925.826.622.145-5429.127.526.323.425.224.021.520.620.717.917.714.255-6451.745.047.642.041.838.737.134.333.033.134.729.165+90.587.388.284.381.178.677.170.973.171.969.565.565-7484.381.379.777.074.270.068.361.363.662.859.355.575-84138.0130.9148.5131.0119.6125.2119.6116.2115.7108.1109.3101.485+****168.6117.8196.3118.9136.0172.2140.3160.2

30. 30Vol 2, ESRD, Ch 2vol 2 Table 2.17 HP2020 CKD-14.5 Reduce the cardiovascular death rate in persons with a functioning transplant: Target 4.4 deaths per 1,000 patient years at riskData Source: Special analyses, Medicare 5 percent sample. Period prevalent transplant patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012200120022003200420052006200720082009201020112012All5.14.84.95.35.45.14.94.14.04.13.53.3American Indian or Alaskan Native only*10.7***8.8******Asian only*3.8**2.33.63.0***2.02.2Native Hawaiian or other Pacific Islander only************Black or Af Am only6.65.65.86.06.05.95.35.04.94.84.23.9White only5.04.64.95.45.45.05.04.04.04.23.43.2Two or more races********4.4***Hispanic or Latino3.24.03.43.03.94.13.23.43.42.83.12.2Not Hispanic or Latino5.44.95.15.55.65.25.14.14.14.33.53.4Black or Af Am only, not Hispanic/Latino6.75.75.76.16.16.05.45.15.04.84.24.0

31. Vol 2, ESRD, Ch 231vol 2 Table 2.17 HP2020 CKD-14.5 Reduce the cardiovascular death rate in persons with a functioning transplant: Target 4.4 deaths per 1,000 patient years at risk(continued)Data Source: Special analyses, Medicare 5 percent sample. Period prevalent transplant patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviations: Af Am, African American; CKD, chronic kidney disease.200120022003200420052006200720082009201020112012Male5.65.25.25.95.85.35.64.54.04.63.83.3Female4.54.34.44.44.74.73.93.44.03.42.93.3<18************0-4************5-11************12-17************18-442.32.32.22.22.11.91.91.61.31.31.01.018-24************25-442.42.42.32.42.21.92.01.71.41.41.01.145-646.25.45.55.85.85.54.94.13.73.93.32.845-545.74.04.34.84.54.14.23.23.12.82.21.955-647.07.27.07.07.27.05.85.14.44.94.43.765+12.212.212.012.913.211.311.48.79.79.27.47.265-7412.210.910.612.112.810.010.08.08.38.66.86.275-8412.021.622.418.115.518.718.212.516.411.29.311.385+************